IDEX (IEX) Aktienübersicht
Die IDEX Corporation bietet zusammen mit ihren Tochtergesellschaften angewandte Lösungen in den Vereinigten Staaten, Nordamerika, Europa, Asien und international an. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 2/6 |
| Künftiges Wachstum | 1/6 |
| Vergangene Leistung | 5/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 4/6 |
Belohnungen
Risikoanalyse
Bei unseren Risikoprüfungen wurden keine Risiken für IEX festgestellt.
IEX Community Fair Values
Create NarrativeSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
IDEX Corporation Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$238.94 |
| 52-Wochen-Hoch | US$243.80 |
| 52-Wochen-Tief | US$158.19 |
| Beta | 0.98 |
| 1 Monat Veränderung | 6.87% |
| 3 Monate Veränderung | 15.05% |
| 1 Jahr Veränderung | 45.01% |
| 3 Jahre Veränderung | 8.90% |
| 5 Jahre Veränderung | 7.98% |
| Veränderung seit IPO | 8,171.00% |
Aktuelle Nachrichten und Updates
Narrative-Update • Aug 14
IEX: Strong Buy Ratings And Ongoing Buybacks Will Support Future Returns
Analysts have increased their price target for IDEX to $254.50 from $248, reflecting updated assumptions for revenue growth, profit margins and a slightly different discount rate, while leaving long term P/E expectations broadly unchanged. What’s in the News for IDEX Analysts at RBC Capital have kept a Buy rating on IDEX Corporation and set a price target of US$280, according to recent research coverage.Narrative-Update • Jul 30
IEX: Ongoing Buybacks And Long Dividend Streak Will Support Future Returns
Analysts have raised their price target for IDEX to $248 from $238.29, citing updated assumptions that reflect the latest views on growth, profitability, and valuation multiples. What’s in the News for IDEX IDEX reported that from April 1, 2026 to June 30, 2026, the company repurchased 364,270 shares for US$77 million, representing 0.49% of its shares under an ongoing buyback program.Seeking Alpha • Jul 03
IDEX Corporation: Healthy End-Market Demand Supports Growth, But Premium Valuation Warrants Caution
Summary IDEX Corporation is rated Hold, as its premium P/E valuation is not justified by growth relative to peers. Strong HST segment growth and AI-driven demand should drive FY2026 revenue, but FMT segment weakness remains a headwind. Margins benefit from volume leverage and favorable price/cost, but unfavorable mix and low-margin acquisitions pressure profitability. With a 26.48x P/E versus a 21.8x peer median, IEX's superior margins do not warrant the current valuation premium. Read the full article on Seeking AlphaRecent updates
Narrative-Update • Aug 14
IEX: Strong Buy Ratings And Ongoing Buybacks Will Support Future Returns
Analysts have increased their price target for IDEX to $254.50 from $248, reflecting updated assumptions for revenue growth, profit margins and a slightly different discount rate, while leaving long term P/E expectations broadly unchanged. What’s in the News for IDEX Analysts at RBC Capital have kept a Buy rating on IDEX Corporation and set a price target of US$280, according to recent research coverage.Narrative-Update • Jul 30
IEX: Ongoing Buybacks And Long Dividend Streak Will Support Future Returns
Analysts have raised their price target for IDEX to $248 from $238.29, citing updated assumptions that reflect the latest views on growth, profitability, and valuation multiples. What’s in the News for IDEX IDEX reported that from April 1, 2026 to June 30, 2026, the company repurchased 364,270 shares for US$77 million, representing 0.49% of its shares under an ongoing buyback program.Seeking Alpha • Jul 03
IDEX Corporation: Healthy End-Market Demand Supports Growth, But Premium Valuation Warrants Caution
Summary IDEX Corporation is rated Hold, as its premium P/E valuation is not justified by growth relative to peers. Strong HST segment growth and AI-driven demand should drive FY2026 revenue, but FMT segment weakness remains a headwind. Margins benefit from volume leverage and favorable price/cost, but unfavorable mix and low-margin acquisitions pressure profitability. With a 26.48x P/E versus a 21.8x peer median, IEX's superior margins do not warrant the current valuation premium. Read the full article on Seeking AlphaAnalyseartikel • Jun 16
Idex (IEX) Stock Valuation Check After Recent Gains And Conflicting P/E And DCF Signals
Recent performance snapshot and what it means for IDEX (IEX) IDEX (IEX) has drawn fresh attention after a steady run, with the stock last closing at US$222.04 and total return figures highlighting how the company has been tracking over different holding periods. Over the past month, IDEX shows a 6.9% return, and about 16.6% over the past 3 months, with year to date performance at 24% and a 1 year total return of 25.3%. Longer holding periods show total returns of 10.3% over 3 years and 9%...Narrative-Update • Jun 16
IEX: Steady Buybacks And Dividend Record Will Support Future Returns
Analysts have nudged their price target on IDEX slightly higher to about $238 per share, reflecting small adjustments to fair value, discount rate, long term revenue growth, profit margin, and future P/E assumptions in their models. What's in the News IDEX's board approved a regular quarterly cash dividend of US$0.73 per common share, scheduled for payment on June 5, 2026, to shareholders of record on May 22, 2026, marking the company’s 126th consecutive regular quarterly dividend (Key Developments).Narrative-Update • Jun 01
IEX: Dividend Strength And AI-Driven Demand Should Support Future Returns
Analysts have maintained their $237.71 price target for IDEX, citing only very small adjustments in the discount rate, revenue growth, profit margin, and future P/E assumptions as the reasons for leaving their valuation unchanged. What's in the News IDEX reported first quarter fiscal 2026 results that came in stronger than expected, according to recent Wall Street coverage.Narrative-Update • May 14
IEX: Dividend Strength And Buybacks Will Support Returns Going Forward
Analysts have adjusted their price target on IDEX to $237.71 from $222.71, reflecting updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News IDEX Corporation's Board of Directors approved a regular quarterly cash dividend of $0.73 per common share, scheduled to be paid on June 5, 2026, to shareholders of record on May 22, 2026.Narrative-Update • Apr 26
IEX: Balanced Outlook As Buybacks And M&A Plans Will Shape Returns
Analysts now project only a slight reduction in IDEX's fair value estimate, with the updated price target moving from about $222.93 to $222.71. This reflects modest adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E.Narrative-Update • Apr 12
IEX: Balanced Outlook As Buybacks And M&A Plans Shape Future Returns
Analysts have inched their price target for IDEX lower to about $223 from roughly $224, reflecting slightly revised assumptions on fair value, discount rate and forward P/E, while keeping revenue growth and profit margin expectations broadly unchanged. What's in the News IDEX completed a share repurchase tranche from October 1, 2025 to February 19, 2026, buying 632,280 shares for US$113.1 million, equal to 0.84% of shares under the existing program (Key Developments).Narrative-Update • Mar 28
IEX: Ongoing Buybacks And M&A Focus Will Support Future Upside
Analysts have slightly reduced their IDEX price target to $224.29 from $225.08, citing minor model updates to fair value, discount rate, revenue growth, profit margin, and forward P/E assumptions. What's in the News IDEX completed a share repurchase program announced on April 21, 2008, buying back a total of 19,293,107 shares for US$1,623.91m, representing 24.31% of the company (Key Developments).Narrative-Update • Mar 14
IEX: Ongoing M&A And Buybacks Will Support Attractive Future Upside
Analysts have raised their price target on IDEX to about $225 from roughly $224, reflecting slightly updated assumptions around the discount rate, revenue growth, profit margin, and forward P/E. What's in the News IDEX is actively pursuing mergers and acquisitions, with management describing the company as about halfway through a multiyear capital deployment cycle focused on building out existing platforms and markets (Key Developments).Narrative-Update • Feb 27
IEX: Future CFO And Continued M&A Will Support Steady Outlook
Analysts have kept their average IDEX price target broadly steady around $223.54, with only marginal tweaks to inputs such as the discount rate and assumed future P/E multiple to reflect updated views on the company’s risk profile and valuation framework. What's in the News IDEX is actively pursuing mergers and acquisitions, with management indicating they see themselves around the midpoint of a long term capital deployment cycle and planning additional deals to build out existing market positions, using prior acquisition activity as a reference point for future bolt on targets (Key Developments).Narrative-Update • Feb 13
IEX: Future CFO Transition And Ongoing Buybacks Will Support Steady Outlook
Analysts have lifted their price target on IDEX to $223.54 from $198.62, reflecting updated assumptions that include a slightly lower discount rate and modest tweaks to revenue growth, profit margin, and future P/E expectations. What's in the News IDEX completed a share repurchase tranche between October 1, 2025 and December 31, 2025, buying 400,000 shares, or 0.53% of the company, for $75 million under its long running buyback program announced on April 21, 2008 (Key Developments).Narrative-Update • Jan 30
IEX: Future CFO Transition And Capital Deployment Will Support Steady Outlook
Analysts have nudged their price target on IDEX higher to about US$199 from roughly US$197, citing updated assumptions that include a slightly lower discount rate, modest tweaks to revenue growth and profit margin expectations, and a marginally higher future P/E estimate. What's in the News IDEX appointed Sean M.Narrative-Update • Jan 15
IEX: Future CFO Appointment And Buybacks Will Support Steady Outlook
Analysts have modestly raised their fair value estimate for IDEX to US$197.08 from US$194.62, citing slightly lower assumed revenue growth and profit margins that are offset by a higher future P/E multiple and updated discount rate assumptions. What's in the News IDEX appointed Sean M.Analyseartikel • Jan 07
These 4 Measures Indicate That IDEX (NYSE:IEX) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Seeking Alpha • Apr 27
IDEX Corporation: It's Best To Remain Cautious As Earnings Near
Summary IDEX Corporation's stock has fallen 19.3% since last July, but I still rate it a 'hold' due to its high valuation. Revenue and profitability metrics for IDEX have been volatile, with mixed results across its three main business segments. Management's 2025 guidance suggests modest revenue growth and improved earnings, but economic uncertainty and potential tariff impacts remain concerns. Awaiting Q1 2025 results on May 1st, IDEX's stock remains fairly valued compared to peers, but not attractive enough for an upgrade. Read the full article on Seeking AlphaSeeking Alpha • Feb 09
IDEX: A Wonderful Mid-Cap Focused On Long-Term Value Generation
Summary IDEX Corporation is a niche industrial manufacturer with a wide economic moat, producing mission-critical products with significant pricing power and high switching costs. Despite softer 2024 earnings, IDEX remains highly profitable with robust margins and a strong balance sheet. The firm's strategic acquisitions and entrenched customer relationships bolster its market position, ensuring continued growth and competitive insulation. Given the fair valuation and conservative fiscal management, I rate IDEX a Hold, awaiting a larger undervaluation for a potential buy. Read the full article on Seeking AlphaSeeking Alpha • Nov 06
IDEX Corporation: A Demanding Valuation For A Great Business
Summary IDEX Corporation faces sluggish organic growth and slower order intake, yet it maintains a strong long-term value proposition through mission-critical industrial and technology solutions. Despite a solid historical performance, current valuation multiples are demanding, especially given the flattish reported results. The company’s recent $1 billion acquisition of Mott is strategically aligned but comes at a high valuation, reflecting IDEX’s increased reliance on M&A for growth. Shares have risen to $235, driven by optimism, but I remain cautious due to lackluster operating performance and heightened expectations at nearly 30 times earnings. Read the full article on Seeking AlphaSeeking Alpha • Sep 02
IDEX Corp. Q2: Project Delay And Weakness In Life Science
Summary I reiterate a 'Buy' rating for IDEX, with a fair price target of $220 per share, despite near-term headwinds in organic revenue and market softness. IDEX's acquisition of Mott Corporation for $1 billion is strategically favorable, enhancing their applied material science technology and potentially improving overall margins. Project delays and market weakness, particularly in the life science sector, have led to a 4% organic revenue decline and lowered full-year growth guidance. Long-term growth prospects remain strong due to active portfolio management, strategic acquisitions, and anticipated recovery in industrial activities and life science markets by 2025. Read the full article on Seeking AlphaSeeking Alpha • Jul 11
IDEX Corp.: There Are Better Opportunities Out There
Summary IDEX Corporation's revenue grew slightly in 2024, but profitability weakened due to a drop in sales and rising costs. Management remains optimistic about organic revenue growth and adjusted net income for the year. Despite being a high-quality business, IDEX Corporation's shares are not attractively priced, making it a better 'hold' than a 'buy' prospect. Read the full article on Seeking AlphaAktionärsrenditen
| IEX | US Machinery | US Markt | |
|---|---|---|---|
| 7D | 1.9% | -0.5% | 0.6% |
| 1Y | 45.0% | 37.4% | 19.9% |
Rendite im Vergleich zur Industrie: IEX übertraf die Branche US Machinery , die im vergangenen Jahr eine Rendite von 37.4 erzielte.
Rendite vs. Markt: IEX übertraf den Markt US, der im vergangenen Jahr eine Rendite von 19.9 erzielte.
Preisvolatilität
| IEX volatility | |
|---|---|
| IEX Average Weekly Movement | 2.8% |
| Machinery Industry Average Movement | 6.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiler Aktienkurs: IEX hatte in den letzten 3 Monaten im Vergleich zum US -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: IEXDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1987 | 8,700 | Eric Ashleman | www.idexcorp.com |
Die IDEX Corporation bietet zusammen mit ihren Tochtergesellschaften angewandte Lösungen in den Vereinigten Staaten, Nordamerika, Europa, Asien und international an. Das Unternehmen ist in drei Segmenten tätig: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) und Fire & Safety/Diversified Products (FSDP). Das Segment HST entwickelt, produziert und vertreibt eine Reihe von Präzisionsfluidikprodukten, Verdrängerpumpen, Pulver- und Flüssigkeitsverarbeitungstechnologien, Trocknungssysteme, Mikropräzisionskomponenten, pneumatische Komponenten und Dichtungslösungen, hochleistungsfähige gegossene und extrudierte Dichtungskomponenten sowie kundenspezifische Gleitring- und Wellendichtungen.
IDEX Corporation's Grundlagenzusammenfassung
| IEX grundlegende Statistiken | |
|---|---|
| Marktanteil | US$17.63b |
| Gewinn(TTM) | US$519.50m |
| Umsatz(TTM) | US$3.59b |
33.9x
Kurs-Gewinn-Verhältnis 4.9x
Kurs-Umsatz-VerhältnisIst IEX zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| IEX Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$3.59b |
| Kosten der Einnahmen | US$1.98b |
| Bruttogewinn | US$1.60b |
| Sonstige Ausgaben | US$1.08b |
| Gewinn | US$519.50m |
Zuletzt gemeldete Gewinne
Jun 30, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 7.05 |
| Bruttomarge | 44.73% |
| Nettogewinnspanne | 14.49% |
| Schulden/Eigenkapital-Verhältnis | 46.4% |
Wie hat sich IEX auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
1.2%
Aktuelle Dividendenrendite41%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/08/14 09:14 |
| Aktienkurs zum Tagesende | 2026/08/14 00:00 |
| Gewinne | 2026/06/30 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
IDEX Corporation wird von 28 Analysten beobachtet. 13 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| John Eade | Argus Research Company |
| Michael Halloran | Baird |
| Walter Liptak | Barrington Research Associates, Inc. |